Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Prevention of Myocardial Dysfunction and Injury Resulting From Salter Innominate Osteotomy by Caudal Block

24 de agosto de 2014 actualizado por: Si-Qin Chen

Prevention of Pro-inflammatory Cytokines-associated Myocardial Dysfunction and Injury Resulting From Salter Innominate Osteotomy by Caudal Block

The goal of the present study was to investigate the role of pro-inflammatory cytokines in myocardial dysfunction and injury resulting from noncardiac injury in children and whether or not anti-inflammatory treatment with caudal block prevents pro-inflammatory cytokines-associated myocardial dysfunction and injury following noncardiac surgery.

Descripción general del estudio

Estado

Desconocido

Intervención / Tratamiento

Tipo de estudio

Intervencionista

Inscripción (Anticipado)

40

Fase

  • Fase 4

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Ubicaciones de estudio

      • Shanghai, Porcelana, 200092
        • Reclutamiento
        • Xinhua Hospital

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

1 año a 5 años (Niño)

Acepta Voluntarios Saludables

No

Géneros elegibles para el estudio

Todos

Descripción

Inclusion Criteria:

  • Children diagnosed for developmental dysplasia of the hip (DDH) undergoing Salter innominate osteotomy will be recruited into the study.

Exclusion Criteria:

  • Children with anemia, electrolyte disturbances, abnormal acid-base status, bleeding diathesis, history of allergy to local anesthetics, neurologic and spinal diseases, skin infections on the caudal area, renal dysfunction, symptomatic cardiovascular and respiratory disease

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Prevención
  • Asignación: Aleatorizado
  • Modelo Intervencionista: Asignación paralela
  • Enmascaramiento: Cuadruplicar

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Experimental: Ropivacaine
caudal block with 1 ml/kg of ropivacaine 0.2%
caudal block with 1 ml/kg of ropivacaine 0.2%
Comparador de placebos: saline
caudal block with 1 ml/kg of saline
caudal block with 1 ml/kg of saline

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Periodo de tiempo
change from baseline(before induction of anesthesia) in plasma concentrations of NT(N terminal)-proBNP at arrival in the postanesthesia care unit
Periodo de tiempo: baseline(before induction of anesthesia), arrival in the postanesthesia care unit
baseline(before induction of anesthesia), arrival in the postanesthesia care unit
change from baseline(before induction of anesthesia) in plasma concentrations of NT(N terminal)-proBNP at 3h after surgery
Periodo de tiempo: baseline(before induction of anesthesia), 3h after surgery
baseline(before induction of anesthesia), 3h after surgery
change from baseline(before induction of anesthesia) in plasma concentrations of NT(N terminal)-proBNP at 24h after surgery
Periodo de tiempo: baseline(before induction of anesthesia), 24h after surgery
baseline(before induction of anesthesia), 24h after surgery
change from baseline(before induction of anesthesia) in plasma concentrations of NT(N terminal)-proBNP at 48h after surgery
Periodo de tiempo: baseline(before induction of anesthesia), 48h after surgery
baseline(before induction of anesthesia), 48h after surgery
change from baseline(before induction of anesthesia) in plasma concentrations of NT(N terminal)-proBNP at 72h after surgery
Periodo de tiempo: baseline(before induction of anesthesia), 72h after surgery
baseline(before induction of anesthesia), 72h after surgery
change from baseline(before induction of anesthesia) in plasma concentrations of CK(creatine kinase)-MB at arrival in the postanesthesia care unit
Periodo de tiempo: baseline(before induction of anesthesia), arrival in the postanesthesia care unit
baseline(before induction of anesthesia), arrival in the postanesthesia care unit
change from baseline(before induction of anesthesia) in plasma concentrations of CK(creatine kinase)-MB at 3h after surgery
Periodo de tiempo: baseline(before induction of anesthesia), 3h after surgery
baseline(before induction of anesthesia), 3h after surgery
change from baseline(before induction of anesthesia) in plasma concentrations of CK(creatine kinase)-MB at 24h after surgery
Periodo de tiempo: baseline(before induction of anesthesia), 24h after surgery
baseline(before induction of anesthesia), 24h after surgery
change from baseline(before induction of anesthesia) in plasma concentrations of CK(creatine kinase)-MB at 48h after surgery
Periodo de tiempo: baseline(before induction of anesthesia), 48h after surgery
baseline(before induction of anesthesia), 48h after surgery
change from baseline(before induction of anesthesia) in plasma concentrations of CK(creatine kinase)-MB at 72h after surgery
Periodo de tiempo: baseline(before induction of anesthesia), 72h after surgery
baseline(before induction of anesthesia), 72h after surgery
change from baseline(before induction of anesthesia) in plasma concentrations of cTn(troponin)I at arrival in the postanesthesia care unit
Periodo de tiempo: baseline(before induction of anesthesia), arrival in the postanesthesia care unit
baseline(before induction of anesthesia), arrival in the postanesthesia care unit
change from baseline(before induction of anesthesia) in plasma concentrations of cTn(troponin)I at 3h after surgery
Periodo de tiempo: baseline(before induction of anesthesia), 3h after surgery
baseline(before induction of anesthesia), 3h after surgery
change from baseline(before induction of anesthesia) in plasma concentrations of cTn(troponin)I at 24h after surgery
Periodo de tiempo: baseline(before induction of anesthesia), 24h after surgery
baseline(before induction of anesthesia), 24h after surgery
change from baseline(before induction of anesthesia) in plasma concentrations of cTn(troponin)I at 48h after surgery
Periodo de tiempo: baseline(before induction of anesthesia), 48h after surgery
baseline(before induction of anesthesia), 48h after surgery
change from baseline(before induction of anesthesia) in plasma concentrations of cTn(troponin)I at 72h after surgery
Periodo de tiempo: baseline(before induction of anesthesia), 72h after surgery
baseline(before induction of anesthesia), 72h after surgery
change from baseline(before induction of anesthesia) in plasma concentrations of TNF(tumor necrosis factor)-α at arrival in the postanesthesia care unit
Periodo de tiempo: baseline(before induction of anesthesia), arrival in the postanesthesia care unit
baseline(before induction of anesthesia), arrival in the postanesthesia care unit
change from baseline(before induction of anesthesia) in plasma concentrations of TNF(tumor necrosis factor)-α at 3h after surgery
Periodo de tiempo: baseline(before induction of anesthesia), 3h after surgery
baseline(before induction of anesthesia), 3h after surgery
change from baseline(before induction of anesthesia) in plasma concentrations of TNF(tumor necrosis factor)-α at 24h after surgery
Periodo de tiempo: baseline(before induction of anesthesia), 24h after surgery
baseline(before induction of anesthesia), 24h after surgery
change from baseline(before induction of anesthesia) in plasma concentrations of TNF(tumor necrosis factor)-α at 48h after surgery
Periodo de tiempo: baseline(before induction of anesthesia), 48h after surgery
baseline(before induction of anesthesia), 48h after surgery
change from baseline(before induction of anesthesia) in plasma concentrations of TNF(tumor necrosis factor)-α at 72h after surgery
Periodo de tiempo: baseline(before induction of anesthesia), 72h after surgery
baseline(before induction of anesthesia), 72h after surgery
change from baseline(before induction of anesthesia) in plasma concentrations of IL(interleukin)-6 at arrival in the postanesthesia care unit
Periodo de tiempo: baseline(before induction of anesthesia), arrival in the postanesthesia care unit
baseline(before induction of anesthesia), arrival in the postanesthesia care unit
change from baseline(before induction of anesthesia) in plasma concentrations of IL(interleukin)-6 at 3h after surgery
Periodo de tiempo: baseline(before induction of anesthesia), 3h after surgery
baseline(before induction of anesthesia), 3h after surgery
change from baseline(before induction of anesthesia) in plasma concentrations of IL(interleukin)-6 at 24h after surgery
Periodo de tiempo: baseline(before induction of anesthesia), 24h after surgery
baseline(before induction of anesthesia), 24h after surgery
change from baseline(before induction of anesthesia) in plasma concentrations of IL(interleukin)-6 at 48h after surgery
Periodo de tiempo: baseline(before induction of anesthesia), 48h after surgery
baseline(before induction of anesthesia), 48h after surgery
change from baseline(before induction of anesthesia) in plasma concentrations of IL(interleukin)-6 at 72h after surgery
Periodo de tiempo: baseline(before induction of anesthesia), 72h after surgery
baseline(before induction of anesthesia), 72h after surgery

Medidas de resultado secundarias

Medida de resultado
Periodo de tiempo
change from baseline(just before the start of surgery) in MAP(mean arterial pressure) at arrival in the postanesthesia care unit
Periodo de tiempo: baseline(just before the start of surgery), at arrival in the postanesthesia care unit
baseline(just before the start of surgery), at arrival in the postanesthesia care unit
change from baseline(just before the start of surgery) in MAP(mean arterial pressure) at 3h after surgery
Periodo de tiempo: baseline(just before the start of surgery), 3h after surgery
baseline(just before the start of surgery), 3h after surgery
change from baseline(just before the start of surgery) in CVP(central venous pressure) at arrival in the postanesthesia care unit
Periodo de tiempo: baseline(just before the start of surgery), at arrival in the postanesthesia care unit
baseline(just before the start of surgery), at arrival in the postanesthesia care unit
change from baseline(just before the start of surgery) in CVP(central venous pressure) at 3h after surgery
Periodo de tiempo: baseline(just before the start of surgery), 3h after surgery
baseline(just before the start of surgery), 3h after surgery
change from baseline(just before the start of surgery) in HR(heart rate) at arrival in the postanesthesia care unit
Periodo de tiempo: baseline(just before the start of surgery), at arrival in the postanesthesia care unit
baseline(just before the start of surgery), at arrival in the postanesthesia care unit
change from baseline(just before the start of surgery) in HR(heart rate) at 3h after surgery
Periodo de tiempo: baseline(just before the start of surgery), 3h after surgery
baseline(just before the start of surgery), 3h after surgery

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Patrocinador

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio

1 de abril de 2014

Finalización primaria (Anticipado)

1 de septiembre de 2014

Finalización del estudio (Anticipado)

1 de octubre de 2014

Fechas de registro del estudio

Enviado por primera vez

11 de mayo de 2014

Primero enviado que cumplió con los criterios de control de calidad

19 de mayo de 2014

Publicado por primera vez (Estimar)

22 de mayo de 2014

Actualizaciones de registros de estudio

Última actualización publicada (Estimar)

26 de agosto de 2014

Última actualización enviada que cumplió con los criterios de control de calidad

24 de agosto de 2014

Última verificación

1 de agosto de 2014

Más información

Términos relacionados con este estudio

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir